Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer

BACKGROUND: Gemcitabine and nab-paclitaxel (GA) is a first-line treatment for patients with metastatic pancreatic cancer (mPDAC). The traditional dosing schedule of GA is days 1, 8, and 15 of a 28-day cycle. Frequently, older adults are given a modified dosing schedule using 2 doses per cycle becaus...

Descripción completa

Detalles Bibliográficos
Autores principales: Winer, Arthur, Handorf, Elizabeth, Dotan, Efrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438244/
https://www.ncbi.nlm.nih.gov/pubmed/34532641
http://dx.doi.org/10.1093/jncics/pkab074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438244/
https://www.ncbi.nlm.nih.gov/pubmed/34532641
http://dx.doi.org/10.1093/jncics/pkab074

Ejemplares similares